Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status

被引：132
作者：
Ikeda, Y [1 ]
Umemura, K
Kondo, K
Sekiguchi, K
Nakashima, M
机构：
[1] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 43131, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
[3] Hamamatsu Inst Clin Pharmacol & Therapeut, Hamamatsu, Shizuoka, Japan
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 06期
关键词：
D O I：
10.1016/j.clpt.2004.02.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：587 / 588
页数：2
相关论文
共 5 条
  • [1] METOPROLOL AND MEPHENYTOIN OXIDATION POLYMORPHISMS IN FAR EASTERN ORIENTAL SUBJECTS - JAPANESE VERSUS MAINLAND CHINESE
    HORAI, Y
    NAKANO, M
    ISHIZAKI, T
    ISHIKAWA, K
    ZHOU, HH
    ZHOU, BJ
    LIAO, CL
    ZHANG, LM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) : 198 - 207
  • [2] Identification of the cytochrome P450 enzymes involved in the N-oxidation of voriconazole
    Hyland, R
    Jones, BC
    Smith, DA
    [J]. DRUG METABOLISM AND DISPOSITION, 2003, 31 (05) : 540 - 547
  • [3] Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population
    Kubota, T
    Chiba, K
    Ishizaki, T
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) : 661 - 666
  • [4] INTERETHNIC DIFFERENCES IN GENETIC-POLYMORPHISM OF DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION BETWEEN JAPANESE AND CAUCASIAN POPULATIONS
    NAKAMURA, K
    GOTO, F
    RAY, WA
    MCALLISTER, CB
    JACQZ, E
    WILKINSON, GR
    BRANCH, RA
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) : 402 - 408
  • [5] Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients
    Romero, AJ
    Le Pogamp, P
    Nilsson, LG
    Wood, N
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (04) : 226 - 234
1